Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.23p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22p
  • 52 Week Low: 0.20p
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 3,326,997
  • Market Cap: £4.84m
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Huw Jones 3,184,793 £7,166
Toni Hänninen 1,000,000 £2,250

Major Shareholders

Notifier** Holding Value*
Northern Standard Limited 422,727,272 £951,136
TRACARTA LIMITED 422,727,272 £951,136
First Equity Limited 179,000,000 £402,750
T and I Limited 160,000,000 £360,000
Oberon Investments Limited 80,475,000 £181,069
Andrew Leach 80,000,000 £180,000
Simon Gibeon 71,400,000 £160,650
Rathbones Investment Management Ltd 25,789,246 £58,026
Sarum Investment SICAV Plc 25,700,000 £57,825
Octopus Investments Nominees Limited 21,875,000 £49,219
Octopus Investments Nominees Limited 21,875,000 £49,219
Vulpes Investment Management Pte Ltd 20,554,191 £46,247
InterTrader Limited 16,560,033 £37,260
Seneca Partners Limited 16,301,456 £36,678
North West Fund (Biomedical) LP 16,186,446 £36,420
Richard Griffiths and family 14,408,000 £32,418
AXA Framlington Investment Management Limited 13,399,724 £30,149
Chelverton Asset Management 12,500,000 £28,125
RAB Capital 8,750,000 £19,688
David and Monique Newlands 8,314,815 £18,708
Newlands Capital 8,314,815 £18,708
Ali Mortazavi 3,400,000 £7,650
PARTNERS INVESTMENT COMPANY LLP 3,114,089 £7,007
Letzone Limited 2,664,000 £5,994
Beaufort Securities Limited 2,457,568 £5,530
South Yorkshire Investment Capital Fund LP 1,394,550 £3,138

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.23p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22p
52 Week Low 0.20p
Volume 3,326,997
Shares Issued 2,148.96m
Market Cap £4.84m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.77% above the market average13.77% above the market average13.77% above the market average13.77% above the market average13.77% above the market average
86.05% above the sector average86.05% above the sector average86.05% above the sector average86.05% above the sector average86.05% above the sector average
Price Trend
96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average
95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 14-Aug-2025

Time Volume / Share Price
15:14 200,000 @ 0.23p
12:51 3,000,000 @ 0.22p
13:00 124,824 @ 0.22p
12:20 2,173 @ 0.23p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page